MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
Go back to MaxCyte Appoints Douglas Swirsky as Chief Financial Officer| Cellectar Biosciences, Inc. (NASDAQ: CLRB) | Delayed: 2.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.50 | 52 Week High | $6.03 | |||
| Open | $2.50 | 52 Week Low | $0.41 | |||
| Day High | $2.50 | P/E | N/A | |||
| Day Low | $2.50 | EPS | $0.00 | |||
| Volume | 99 | |||||
| GENVEC (NASDAQ: GNVC) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $3.69 | |||
| Open | $316.41 | 52 Week Low | $0.27 | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $-0.95 | |||
| Volume | 5,061 | |||||
| (NASDAQ: REXN) | Delayed: 1.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.81 | 52 Week High | $ | |||
| Open | $21.50 | 52 Week Low | $ | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $ | |||
| Volume | 0 | |||||

